Veterinarians: Get your copy of our 24 page white paper today, covering Treatment of Joint Lameness, Pathophysiology, Manufacturing, Mechanism of Action, Clinical Safety and Putting it into Practice.
Arthramid
Clinical Studies
PROVEN SCIENCE.
PROVEN RESULTS.
PROVEN RESULTS.
Discover the Science Behind Arthramid® 2.5% iPAAG
Arthramid is trusted by veterinarians around the world to treat joint lameness in animals, including horses and dogs. Backed by multiple published studies from leading institutions and with thousands of successful treatments across a range of species and disciplines, Arthramid is a proven, safe, and effective option for managing osteoarthritis and joint-related conditions in veterinary medicine.
Clinical Studies
Histologic and cytologic changes in normal equine joints after injection with 2.5% injectable polyacrylamide hydrogel reveal low-level macrophage-driven foreign body response
Lowe J, de Clifford L, Julian A, Koene M. JAVMA 2024
A double-blinded positive control study comparing the relative efficacy of 2.5% polyacrylamide hydrogel (PAAG) against triamcinolone acetonide (TA) and sodium hyaluronate (HA) in the management of middle carpal joint lameness in racing Thoroughbreds
de Clifford, L.D., Lowe, J.N., McKellar, C.D., Bolwell, C., and David, F. (2021). Journal of Equine Veterinary Science 2021
Initial Estimates of Efficacy of Intra-Articular 2.5% Polyacrylamide Hydrogel for the Treatment of Knee Osteoarthritis: An Observational Proof-of-Concept Study
Henrikson, M., Overgaard, A., and Bliddal, H. Arthritis Rheumatol. 2017;
Intra-articular polyacrylamide hydrogel for the treatment of 20 horses with non-responsive osteoarthritis of the interphalangeal joints: a prospective study
Bathe, A.P., Read, R.M., and Briggs, C. (2016).
Synovial incorporation of polyacrylamide hydrogel after injection into normal and osteoarthritic animal joints
Christensen, L., Illigen, K.E., Hansen, M., Sarvaa, R., and Conogham, P.G. (2016).
Use of a 2.5% Cross-Linked Polyacrylamide Hydrogel in the Management of Joint Lameness in a Population of Flat Racing Thoroughbreds: A Pilot Study
de Clifford, L.D., Lowe, J.N., McKellar, C.D., Bolwell, C., and David, F. Journal of Equine Veterinary Science. 2019
Arthramid White Papers
CANINE WHITE PAPER
Veterinarians: Get your copy of our 21 page white paper today, covering Treatment of Joint Lameness, Pathophysiology, Manufacturing, Mechanism of Action, Clinical Safety and Putting it into Practice.
Testimonials
Dr. Dan Carter
COUNTRYSIDE VETERINARY HOSPITAL - COVINGTON, GA
“Arthramid is a game changer for all equine athletes. It all starts in the synovium with synovitis and capsulitis, before we get to osteoarthritis. I routinely tell my horse owners, ‘save the synovium, save the joint’.”
Dr. Vern Dryden
BUR OAK SPORTS MEDICINE & LAMENESS, LEXINGTON, KY
“It’s given me another tool in my arsenal to effectively manage all stages of equine osteoarthritis, especially those horses with equine metabolic disease.”
Dr Marc Koene
TIERKLINIK LÜSCHE GMBH EQUINE HOSPITAL – NORTHER GERMANY
"We have injected over a thousand horses and have found it to be very safe. It has been a major game-changer in the way we treat OA in our patients.”
Dr Charley McColough
PALM BEACH EQUINE - WELLINGTON, FL
"By incorporating Arthramid into my practice, I’m able to use far fewer steroids while still achieving excellent results, which gives me greater peace of mind for the long-term well-being of the horses under my care."
Dr Bob Peters
MCKINLAY & PETERS EQUINE HOSPITAL - NEWMAN LAKE, WA
"In my opinion, it is efficacious, long-lasting and lower risk to cartilage than many alternatives."
Talk to us for more information
Contact Us